Lifecare ASA
Developing implantable CGM nanosensors for human & veterinary diabetes management.
LIFE | OL
Overview
Corporate Details
- ISIN(s):
- NO0013250563 (+2 more)
- LEI:
- 254900D88MYGZ7JD5P39
- Country:
- Norway
- Address:
- Ytrebygdsvegen 215, 5158 Bergen
- Website:
- https://lifecare.no/
- Sector:
- Manufacturing
- Industry:
- Manufacture of medical and dental instruments and supplies
Description
Lifecare ASA is a clinical-stage medical sensor company developing proprietary nanotechnology for medical monitoring. Its core Sencell technology utilizes osmotic pressure to enable miniaturized, implantable nanobiosensors that can measure various body analytes. The company's primary focus is on diabetes management, with the goal of creating a next-generation Continuous Glucose Monitoring (CGM) system that is painless, accurate, and offers long-term use for both human and veterinary patients. Lifecare is advancing its technology through clinical development and process automation to achieve regulatory approval and commercialization. The company also licenses its technology platform for broader medical and lifestyle applications.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-11-13 10:28 |
Report Publication Announcement
Financial calendar
|
English | 643 bytes | ||
| 2025-11-12 20:34 |
Regulatory News Service
Minutes from Extraordinary General Meeting - Attachment: 2025 11 12 Extraordina…
|
Norwegian | 287.3 KB | ||
| 2025-11-12 20:34 |
Regulatory News Service
Minutes from Extraordinary General Meeting - Attachment: Minutes from Extraordi…
|
Norwegian | 62.0 KB | ||
| 2025-11-12 20:34 |
Post-Annual General Meeting Information
Minutes from Extraordinary General Meeting
|
English | 1.5 KB | ||
| 2025-11-12 07:00 |
Regulatory News Service
LIFE: Lifecare ASA Q3 2025 results - Attachment: Lifecare Q3 2025 Presentation.…
|
Norwegian | 1.6 MB | ||
| 2025-11-12 07:00 |
Regulatory News Service
LIFE: Lifecare ASA Q3 2025 results - Attachment: Q3 2025 Report.pdf
|
Norwegian | 5.3 MB | ||
| 2025-11-12 07:00 |
Earnings Release
LIFE: Lifecare ASA Q3 2025 results
|
English | 4.9 KB | ||
| 2025-11-06 07:00 |
Report Publication Announcement
Lifecare ASA (LIFE): Invitation to presentation of Q3 2025 results - Attachment…
|
English | 53.8 KB | ||
| 2025-11-06 07:00 |
Report Publication Announcement
Lifecare ASA (LIFE): Invitation to presentation of Q3 2025 results
|
English | 2.3 KB | ||
| 2025-11-05 07:00 |
Regulatory News Service
Lifecare shares key learnings from ongoing longevity study LFC-SEN-002 - Attach…
|
English | 71.0 KB | ||
| 2025-11-05 07:00 |
Environmental & Social Information
Lifecare shares key learnings from ongoing longevity study LFC-SEN-002
|
English | 4.2 KB | ||
| 2025-10-28 07:00 |
Regulatory News Service
Lifecare receives update from NOMA on handling time for first-in-human study ap…
|
English | 56.0 KB | ||
| 2025-10-28 07:00 |
Regulatory News Service
Lifecare receives update from NOMA on handling time for first-in-human study ap…
|
English | 2.8 KB | ||
| 2025-10-22 14:00 |
Pre-Annual General Meeting Information
LIFECARE ASA: Extraordinary General Meeting - Attachment: Notice Of EGM 12 Nove…
|
Norwegian | 157.4 KB | ||
| 2025-10-22 14:00 |
Pre-Annual General Meeting Information
LIFECARE ASA: Extraordinary General Meeting - Attachment: LIFECARE ASA- Extraor…
|
English | 65.7 KB |
Automate Your Workflow. Get a real-time feed of all Lifecare ASA filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Lifecare ASA
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Lifecare ASA via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||